Join us at MEDICA 2025 to explore how Accuprec can help accelerate your medical device testing, validation and regulatory submissions.
📍 Hall No. 16 / C35-2 | 📅 17–20 November 2025 | Düsseldorf, Germany • 📧 info@accuprec.com • 🌐 www.accuprec.com
Accuprec Research Labs is a globally recognized Contract Research Organization (CRO) specializing in end-to-end testing, validation and regulatory support for medical devices. Accredited by ISO/IEC 17025, OECD GLP, AAALAC and recognized by global regulatory agencies including USFDA, EMA and ASCA-A2LA, we ensure that every medical device we evaluate meets the highest standards of safety, quality and performance.
With a 1,20,000 sq. ft. state-of-the-art facility, 250+ qualified scientists and operations spanning 13 specialized testing verticals, we serve as an extended R&D and regulatory partner for 1,000+ global manufacturers. Meet our expert team at MEDICA 2025 and discover how Accuprec supports you from concept to clinical validation and market launch.



Ensuring biological safety for every device (ISO 10993 series, USFDA 21 CFR).
Read MoreIdentifying and managing chemical risks; ISO 10993-18/-17 compliance.
Read MoreReal-time, accelerated & transit simulation testing (ASTM, ISTA, ICH).
Read MoreISO 11607 validation, seal strength, sterilant penetration, aging & durability.
Read MoreMDR 2017/745, MEDDEV 2.7/1 Rev. 4, Annex XIV — regulator-ready CERs.
Read MoreBioburden, sterility, endotoxin, PET, EM programs; ISO/USP/WHO compliant.
Read MoreHall No. 16 / C35-2 — 17–20 November 2025, Düsseldorf, Germany
Accuprec Research Labs Pvt. Ltd. © 2026